Retia 2— 510(k) K180293

Substantially Equivalent

Centervue S.P.A.

FDA 510(k) clearance K180293 for Retia 2, Substantially Equivalent on 2018-05-30. Applicant: Centervue S.P.A..

Clearance details

Applicant: Centervue S.P.A.
Product code: Code MYC
Advisory panel: Ophthalmic
Date received: 2018-02-01
Decision date: 2018-05-30
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Padova, IT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.